EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like Lymphomas in mice

Jillian A Bristol, Scott E Nelson, Makoto Ohashi, Alejandro Casco, Mitchell Hayes, Erik A Ranheim, Abigail S Pawelski, Deo R Singh, Daniel J Hodson, Eric C Johannsen, Shannon C Kenney iD

PLOS Pathogens · 2024

DOI: 10.1371/journal.ppat.1012132 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2024. Verfasst von Jillian A Bristol und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, McArdle Laboratory for Cancer Research, School of Medicine and Public Health, University of Wisconsin Madison, Madison, Wisco…. Hauptthemen laut MEDLINE: Burkitt Lymphoma, Epstein-Barr Virus Infections, Herpesvirus 4, Human, Proto-Oncogene Proteins c-myc. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, NCI NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epstein-Barr virus (EBV) is an important cause of human lymphomas, including Burkitt lymphoma (BL). EBV+ BLs are driven by Myc translocation and have stringent forms of viral latency that do not express either of the two major EBV oncoproteins, EBNA2 (which mimics Notch signaling) and LMP1 (which activates NF-κB signaling). Suppression of Myc-induced apoptosis, often through mutation of the TP53 (p53) gene or inhibition of pro-apoptotic BCL2L11 (BIM) gene expression, is required for development of Myc-driven BLs. EBV+ BLs contain fewer cellular mutations in apoptotic pathways compared to EBV-negative BLs, suggesting that latent EBV infection inhibits Myc-induced apoptosis. Here we use an EBNA2-deleted EBV virus (ΔEBNA2 EBV) to create the first in vivo model for EBV+ BL-like lymphomas derived from primary human B cells. We show that cord blood B cells infected with both ΔEBNA2 EBV and a Myc-expressing vector proliferate indefinitely on a CD40L/IL21 expressing feeder layer in vitro and cause rapid onset EBV+ BL-like tumors in NSG mice. These LMP1/EBNA2-negative Myc-driven lymphomas have wild type p53 and very low BIM, and express numerous germinal center B cell proteins (including TCF3, BACH2, Myb, CD10, CCDN3, and GCSAM) in the absence of BCL6 expression. Myc-induced activation of Myb mediates expression of many of these BL-associated proteins. We demonstrate that Myc blocks LMP1 expression both by inhibiting expression of cellular factors (STAT3 and Src) that activate LMP1 transcription and by increasing expression of proteins (DNMT3B and UHRF1) known to enhance DNA methylation of the LMP1 promoters in human BLs. These results show that latent EBV infection collaborates with Myc over-expression to induce BL-like human B-cell lymphomas in mice. As NF-κB signaling retards the growth of EBV-negative BLs, Myc-mediated repression of LMP1 may be essential for latent EBV infection and Myc translocation to collaboratively induce human BLs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Burkitt LymphomaEpstein-Barr Virus InfectionsHerpesvirus 4, HumanProto-Oncogene Proteins c-mycB-LymphocytesVirus LatencyAnimalsHumansMiceEpstein-Barr Virus Nuclear AntigensApoptosisViral Proteins

Substanzen

Proto-Oncogene Proteins c-mycEpstein-Barr Virus Nuclear AntigensMYC protein, humanEBNA-2 protein, Human herpesvirus 4Viral Proteins

Autor:innen und Institutionen

  • Department of Oncology, McArdle Laboratory for Cancer Research, School of Medicine and Public Health, University of Wisconsin Madison, Madison, Wisconsin, United States of America.
  • Department of Pathology, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
  • Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.
  • Department of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.

ORCID-Profile: Shannon C Kenney

Förderung

  • Medical Research Council
  • NCI NIH HHS
  • NIAID NIH HHS
  • Wellcome Trust
  • National Institutes of Health
  • Cancer Research UK Cambridge Institute, University of Cambridge
  • Wellcome - MRC Cambridge Stem Cell Institute, University of Cambridge
  • CRUK and EPSRC Cancer Imaging Centre in Cambridge and Manchester

Zitieren

APA

Bristol, J. A., Nelson, S. E., Ohashi, M., Casco, A., Hayes, M., Ranheim, E. A., Pawelski, A. S., Singh, D. R., Hodson, D. J., Johannsen, E. C., & Kenney, S. C. (2024). Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like Lymphomas in mice. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1012132

Vancouver

Bristol JA, Nelson SE, Ohashi M, Casco A, Hayes M, Ranheim EA, et al. Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like Lymphomas in mice. PLOS Pathogens. 2024. doi:10.1371/journal.ppat.1012132

BibTeX
@article{Bristol2024,
  author = {Bristol, Jillian A and Nelson, Scott E and Ohashi, Makoto and Casco, Alejandro and Hayes, Mitchell and Ranheim, Erik A and Pawelski, Abigail S and Singh, Deo R and Hodson, Daniel J and Johannsen, Eric C and Kenney, Shannon C},
  title = {Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like Lymphomas in mice},
  journal = {PLOS Pathogens},
  year = {2024},
  doi = {10.1371/journal.ppat.1012132}
}
Kostenlos starten →